CVS Health

CVS Health. It is a major American healthcare company with a diversified portfolio spanning retail pharmacy, pharmacy benefit management, and health insurance. Originally founded as a retail health and beauty aid store, the corporation has grown through significant acquisitions, including Caremark, Aetna, and Target's pharmacy business, to become an integrated healthcare services provider. Headquartered in Woonsocket, Rhode Island, it operates thousands of retail locations and serves millions of customers through its PBM and insurance segments, playing a central role in the U.S. healthcare system.

History

The company was founded in 1963 in Lowell, Massachusetts by Stanley Goldstein, his brother Sidney Goldstein, and partner Ralph Hoagland as a chain of health and beauty aid stores, with the name standing for "Consumer Value Stores". It was initially owned by Melville Corporation, a holding company known for retail brands like Thom McAn. A pivotal expansion occurred in 1969 with the purchase of Mack Drug Company, a small New England chain store pharmacy, marking its entry into the prescription drug business. After becoming a standalone public company in 1996, it embarked on a series of transformative acquisitions, including the pharmacy benefit management giant Caremark in 2007, which created a combined PBM and retail powerhouse. Further growth came with the purchase of Target's pharmacy and clinic businesses in 2015 and the landmark $69 billion acquisition of the health insurance leader Aetna in 2018, solidifying its vertically integrated model under the leadership of CEOs like Thomas M. Ryan and later Karen S. Lynch.

Operations and subsidiaries

The corporation's operations are divided into several key business segments. Its Retail/Long-Term Care segment includes the extensive CVS Pharmacy retail chain, with locations nationwide offering prescription drugs, over-the-counter products, and MinuteClinic retail clinic services, alongside Omnicare, which provides pharmacy services to long-term care facilities. The Health Care Benefits segment is anchored by Aetna, a major provider of Medicare, Medicaid, and commercial health insurance plans. The Pharmacy Services segment operates through CVS Caremark, one of the largest PBMs in the United States, administering prescription drug plans for health plan sponsors, including employers, health insurance companies, and government programs, and also includes a specialty pharmacy arm. Additional services are provided through Coram, a home infusion therapy provider, and Accordant, which offers care management for individuals with rare diseases.

Corporate affairs

The company is led by President and CEO Karen S. Lynch and is governed by a Board of Directors that includes figures like David W. Dorman and C. David Brown II. Its corporate headquarters are located in Woonsocket, Rhode Island, a site it has occupied since the 1990s after moving from its original base in Rhode Island's Pawtucket. The firm is a component of the Dow Jones Industrial Average and the S&P 500, reflecting its stature in the American economy. It engages in extensive lobbying efforts in Washington, D.C. and various states, focusing on issues related to pharmaceutical pricing, Medicare, and healthcare regulation. Major institutional shareholders include investment firms like The Vanguard Group, BlackRock, and State Street Corporation.

Financial performance

As a Fortune 500 company, it consistently ranks among the top corporations in the United States by total revenue, which has grown substantially following the Aetna acquisition. Its financial results are reported across its primary segments, with the Health Care Benefits segment now contributing a significant portion of total revenue alongside the Pharmacy Services and Retail/LTC divisions. The company's stock is traded on the New York Stock Exchange under the ticker symbol CVS and is closely watched by Wall Street analysts. Its financial strategy has involved significant capital expenditure on store renovations, digital health initiatives, and integrating its major acquisitions, while also returning capital to shareholders through dividend payments and share repurchase programs.

Controversies and legal issues

The corporation has faced numerous legal and regulatory challenges. It has been involved in major litigation and settlements with federal and state authorities, including the U.S. Department of Justice, over issues such as the alleged improper billing of Medicare and Medicaid programs. Its PBM practices, including drug pricing and rebate arrangements with pharmaceutical manufacturers, have been the subject of scrutiny by the U.S. Senate, the Federal Trade Commission, and multiple state Attorneys General. Other controversies have included settlements related to opioid dispensing practices at its pharmacies and investigations by the Securities and Exchange Commission. The company has also faced criticism and legal action from groups like the American Medical Association regarding its PBM business practices and their impact on independent pharmacies and patient care.

Category:Companies listed on the New York Stock Exchange Category:Healthcare companies of the United States Category:Companies based in Rhode Island